Home | Site Map | Contact Us |  Tell a Colleague | Print Page  
Valcyte valganciclovir HCI tablets Roche
About Roche Transplantation Research Resources for Professionals Prescribing Information Community Support Industry Events/News
Sign Up
Login Here
E-mail
Password
Forgot Password

Important Safety and Prescribing Information

CellCept Zenapax Valcyte Learn More about Product Pipeline

Dosing 

Valcyte features once-daily dosing convenience.

  • 900 mg QD (two 450-mg tablets) is the recommended dose of Valcyte for patients with normal renal function4
  • Valcyte should be taken with food, beginning within 10 days of transplantation and continuing until 100 days posttransplantation4

Dose Modifications for Patients With Renal Impairment4

Cr/Cl (mL/min) Maintenance/Prevention Dose
≥60 900 mg once daily
40-59 450 mg once daily
25-39 450 mg every two days
10-24 450 mg twice weekly

Note: Strict adherence to dose recommendations is essential to avoid overdose.  Valcyte should not be prescribed for patients receiving hemodialysis. For patients on hemodialysis (CrCl < 10mL/min), a dose recommendation cannot be given.

Click here for a creatinine clearance calculator.

  Safety Information

 

Reference:

4Valcyte® [product information]. Nutley, NJ: Roche Laboratories Inc.; January 2006.

Privacy Statement  |  Legal Statement  |  Intended for U.S. Physician Audiences Only Copyright © 2006-2008 - Roche Laboratories Inc. All rights reserved.